Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM
Authors:
Open Access
- 25 November 1997
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 40 (12) , 1449-1454
Abstract
Regulation of mesangial matrix deposition is a dynamic phenomenon involving synthetic and degradative processes. The latter involve a number of matrix metalloproteinases (MMP) and tissue inhibitors of matrix metalloproteinases (TIMP). Experimental studies suggest that mesangial matrix degradation is inhibited in diabetic nephropathy, and that this phenomenon has a pathogenic role. The expression of genes for MMP2 and TIMP2 in human diabetic nephropathy was investigated. Reverse transcription polymerase chain reaction was carried out in microdissected glomeruli and tubulo-interstitium obtained from kidney biopsies. We studied 16 NIDDM patients, 5 patients with glomerulonephritis or chronic kidney transplant rejection, and 5 normal control subjects. Albumin excretion rate and renal histology for NIDDM patients were available. Contrary to TIMP2 which was expressed both in tubulo-interstitium and glomeruli in almost all renal biopsies, MMP2 gene down-regulation was observed in glomeruli from all NIDDM patients, irrespective of the albumin excretion rate, and of renal histology. In contrast, this gene was expressed in biopsies from other subjects (χ2 = 20.6; p = 0.000). In conclusion, this study demonstrates that: 1) in glomeruli of NIDDM patients the MMP2 gene is down-regulated; 2) in biopsies of NIDDM patients the MMP2/TIMP2 pattern is peculiar for NIDDM; 3) the MMP2 gene down-regulation is observed in all NIDDM patients, irrespective of the level of albuminuria and of renal histology. MMP2 gene down-regulation seems to be a molecular epiphenomenon of diabetes, rather than a marker of diabetic nephropathy. [Diabetologia (1997) 40: 1449–1454]Keywords
This publication has 11 references indexed in Scilit:
- Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP- 2/TIMP-2 mRNA expressionNephrology Dialysis Transplantation, 1997
- Patterns of renal injury in NIDDM patients with microalbuminuriaDiabetologia, 1996
- Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitusKidney International, 1996
- Glomerular metalloprotease activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP)Life Sciences, 1994
- Identification and independent regulation of human mesangial cell metalloproteinasesKidney International, 1994
- High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathyDiabetes, 1994
- The emerging role of transforming growth factor-beta in kidney diseasesAmerican Journal of Physiology-Renal Physiology, 1994
- Abnormal Gene Expression of Matrix Metalloproteinases and Their Inhibitor in Glomeruli from Diabetic RatsKidney and Blood Pressure Research, 1994
- Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.Proceedings of the National Academy of Sciences, 1993
- Proteinases and glomerular matrix turnoverKidney International, 1992